{"id":6307,"date":"2025-04-06T11:52:17","date_gmt":"2025-04-06T08:52:17","guid":{"rendered":"https:\/\/jordan-cardiac.org\/?p=6307"},"modified":"2025-04-06T11:52:17","modified_gmt":"2025-04-06T08:52:17","slug":"early-intra-aortic-balloon-pump-in-heart-failure-complicated-by-cardiogenic-shock-the-altshock-2-randomized-clinical-trial-reported-from-acc","status":"publish","type":"post","link":"https:\/\/jordan-cardiac.org\/en\/early-intra-aortic-balloon-pump-in-heart-failure-complicated-by-cardiogenic-shock-the-altshock-2-randomized-clinical-trial-reported-from-acc\/","title":{"rendered":"Early intra-aortic balloon pump in heart failure complicated by cardiogenic shock: The Altshock-2 randomized clinical trial Reported from ACC"},"content":{"rendered":"<div>Early intra-aortic balloon pump in heart failure complicated by cardiogenic shock: The Altshock-2 randomized clinical trial<\/div>\n<div>Reported from ACC.25<\/div>\n<div>31 MAR 2025<\/div>\n<div><\/div>\n<div>The Altshock-2 trial investigated the efficacy of early intra-aortic balloon pump (IABP) implantation in patients with acute decompensated heart failure complicated by cardiogenic shock. Key points from the study include:<\/div>\n<div><span> 1. Study Design: A prospective, randomized, multicenter, open-label trial with blinded outcome assessment.\u00a0<\/span><\/div>\n<div><span> 2. Patient Population: Included patients with hypotension or hypoperfusion , left ventricular ejection fraction &lt;35%, randomized within 6 hours of cardiogenic shock diagnosis.\u00a0<\/span><\/div>\n<div><span> 3. Intervention: Patients were assigned to early IABP implantation or standard vasoactive treatment.\u00a0<\/span><\/div>\n<div><span> 4. Results: No significant difference in primary endpoint (81% in IABP group vs. 75% in control; P=0.45).\u00a0<\/span><\/div>\n<div><span> 5. Safety: Higher rates of bleeding and vascular complications in the IABP group.\u00a0<\/span><\/div>\n<div><\/div>\n<div>The study concluded that early IABP implantation did not offer additional benefit over standard care in this patient population.<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Early intra-aortic balloon pump in heart failure complicated by cardiogenic shock: The Altshock-2 randomized clinical trial Reported from ACC.25 31 MAR 2025 The Altshock-2 trial investigated the efficacy of early intra-aortic balloon pump (IABP) implantation in patients with acute decompensated heart failure complicated by cardiogenic shock. Key points from the study include: 1. Study Design: [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-6307","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts\/6307","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/comments?post=6307"}],"version-history":[{"count":1,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts\/6307\/revisions"}],"predecessor-version":[{"id":6308,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts\/6307\/revisions\/6308"}],"wp:attachment":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/media?parent=6307"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/categories?post=6307"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/tags?post=6307"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}